author-photo

Noriyoshi Iriyama

Nihon University

99

Papers

761

Citations

Citation Trend

Filter By

Papers (76) Sort By

Journal Conference Others

Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Maintenance Therapy With Bortezomib and Dexamethasone for Transplant-ineligible Patients With Multiple Myeloma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment

2021
Show All
- Source
- Cite
- Save
Citations (0)
Nilotinib and Dasatinib Evoked Distinct Immune Effects during Tfr Phase of Each Discontinuation Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Absolute Lymphocyte Counts After Lenalidomide Initiation may Predict the Prognosis of Patients With Relapsed or Refractory Multiple Myeloma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Relationship between Carnitine Deficiency and Tyrosine Kinase Inhibitor Use in Patients with Chronic Myeloid Leukemia.

2021 Chemotherapy
Show All
- Source
- Cite
- Save
Citations (0)
The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

2020 Cancer Medicine
Show All
- Source
- Cite
- Save
Citations (3)
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (21)
Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

2020 Blood
Show All
- Source
- Cite
- Save
Citations (6)
[Transformation of CD5-positive nodal marginal zone lymphoma to diffuse large B-cell lymphoma].

2020 The Japanese journal of clinical hematology
Show All
- Source
- Cite
- Save
Citations (0)